Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
4.400
+0.050 (1.15%)
At close: Aug 13, 2025, 4:00 PM
4.250
-0.150 (-3.41%)
Pre-market: Aug 14, 2025, 9:22 AM EDT
Liminatus Pharma Market Cap
Liminatus Pharma has a market cap or net worth of $114.46 million as of August 14, 2025. Its market cap has increased by 33.16% in one year.
Market Cap
114.46M
Enterprise Value
134.38M
1-Year Change
33.16%
Ranking
Category
Stock Price
$4.40
Market Cap Chart
Since May 26, 2021, Liminatus Pharma's market cap has decreased from $346.04M to $114.46M, a decrease of -66.92%. That is a compound annual growth rate of -23.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 114.46M | 42.90% |
| Dec 31, 2024 | 80.10M | 6.12% |
| Dec 27, 2023 | 75.48M | -78.38% |
| Dec 30, 2022 | 349.14M | 3.48% |
| Dec 31, 2021 | 337.41M | -2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |